Crown Bioscience International, often referred to as CrownBio, is a leading global provider of preclinical and translational research services, headquartered in Taiwan (TW). Established in 2006, the company has rapidly expanded its operational footprint across North America, Europe, and Asia, positioning itself as a key player in the biotechnology and pharmaceutical industries. CrownBio specialises in offering innovative solutions in drug discovery and development, with a focus on oncology, immunology, and metabolic diseases. Their unique suite of services includes patient-derived xenograft (PDX) models and advanced in vitro assays, which are designed to accelerate the drug development process. Recognised for its commitment to quality and scientific excellence, CrownBio has achieved significant milestones, including partnerships with major pharmaceutical companies, solidifying its reputation as a trusted partner in the life sciences sector.
We don't have data for Crown Bioscience International, but we can show you information about their parent organization instead.
View parent company